| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1016536458 |
| P356 | DOI | 10.1023/A:1018840105188 |
| P698 | PubMed publication ID | 9753287 |
| P2093 | author name string | D Häussinger | |
| C Niederau | |||
| T Heintges | |||
| L Mohr | |||
| F Hensel | |||
| P2860 | cites work | A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group | Q28243457 |
| Antimitochondrial antibody negative primary biliary cirrhosis: a distinct syndrome of autoimmune cholangitis | Q34377943 | ||
| A 33-year-old woman with an autoimmune syndrome | Q43550973 | ||
| M4 and M9 antibodies in the overlap syndrome of primary biliary cirrhosis and chronic active hepatitis: epitopes or epiphenomena? | Q46809632 | ||
| The Canadian Multicenter Double-blind Randomized Controlled Trial of ursodeoxycholic acid in primary biliary cirrhosis | Q49110706 | ||
| Ursodiol for the long-term treatment of primary biliary cirrhosis. The UDCA-PBC Study Group. | Q54118475 | ||
| Chronic active hepatitis with histological features of primary biliary cirrhosis | Q68822637 | ||
| [A chronic destructive non-suppurative cholangitis-like disease picture with antinuclear antibodies (immunocholangitis)] | Q69211179 | ||
| Ursodeoxycholic acid in primary biliary cirrhosis: results of a controlled double-blind trial | Q69357047 | ||
| [Diagnosis and therapy of autoimmune hepatitis] | Q71547168 | ||
| Antimitochondrial antibody-negative chronic nonsuppurative destructive cholangitis. Atypical primary biliary cirrhosis or autoimmune cholangitis? | Q71741371 | ||
| Primary biliary cirrhosis | Q71742524 | ||
| Autoimmune cholangiopathy: part of the spectrum of autoimmune chronic active hepatitis | Q72224539 | ||
| Antibodies to carbonic anhydrase in patients with immune cholangiopathies | Q72281881 | ||
| Autoimmune cholangitis: a variant of primary biliary cirrhosis. Clinicopathologic and serologic correlations in 200 cases | Q72313586 | ||
| Ursodeoxycholic acid in the treatment of primary biliary cirrhosis | Q72401649 | ||
| Antimitochondrial antibody-negative primary biliary cirrhosis | Q72524305 | ||
| Primary autoimmune cholangitis. An alternative to antimitochondrial antibody-negative primary biliary cirrhosis | Q72702326 | ||
| Comparison of the clinical features and clinical course of antimitochondrial antibody-positive and -negative primary biliary cirrhosis | Q73319901 | ||
| Does antimitochondrial antibody status affect response to treatment in patients with primary biliary cirrhosis? Outcomes of ursodeoxycholic acid therapy and liver transplantation | Q73491973 | ||
| P433 | issue | 9 | |
| P304 | page(s) | 2160-2163 | |
| P577 | publication date | 1998-09-01 | |
| P1433 | published in | Digestive Diseases and Sciences | Q15716711 |
| P1476 | title | Treatment of autoimmune cholangitis | |
| P478 | volume | 43 |
| Q35030826 | Review article: is there an optimal therapeutic regimen for antimitochondrial antibody-negative primary biliary cirrhosis (autoimmune cholangitis)? | cites work | P2860 |
Search more.